Neuromuscular Disease News and Research

RSS
MDA awards $14.1 million in new grants to advance treatments and cures for muscle diseases

MDA awards $14.1 million in new grants to advance treatments and cures for muscle diseases

Rxi Pharmaceuticals second-quarter net loss decreases to $2.1 million

Rxi Pharmaceuticals second-quarter net loss decreases to $2.1 million

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

Acceleron's ACE-031 protein therapeutic for DMD receives FDA Fast Track designation

Prosensa, GSK initiate additional programs for DMD

Prosensa, GSK initiate additional programs for DMD

UF administers Lumizyme for late-onset Pompe disease

UF administers Lumizyme for late-onset Pompe disease

UF doctors administer newly available therapy for late-onset Pompe disease

UF doctors administer newly available therapy for late-onset Pompe disease

Pharnext closes €4.8-million Series A funding round

Pharnext closes €4.8-million Series A funding round

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

Acceleron Pharma commences Phase 2 clinical trial of ACE-031 protein therapeutic in DMD patients

Acceleron Pharma commences Phase 2 clinical trial of ACE-031 protein therapeutic in DMD patients

Medication used to treat heart arrhythmias also reduces myotonic dystrophy: Researchers

Medication used to treat heart arrhythmias also reduces myotonic dystrophy: Researchers

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

Hospital for Special Care launches ALS Clinical Trials Unit at Neuromuscular Center

New therapeutic approach for Duchenne muscular dystrophy

New therapeutic approach for Duchenne muscular dystrophy

MDA awards over $21M in grants for advancing critical neuromuscular research

MDA awards over $21M in grants for advancing critical neuromuscular research

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

RXi Pharmaceuticals, miRagen Therapeutics enter into research collaboration

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

Team of neurologists from the U.S. face Canadian neurologists in annual "Neurobowl"

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

Barrow Neurological Institute scientist receives grant to study myasthenia gravis

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

MDA awards 42 medical researchers and labs over $21M for critical neuromuscular research

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients